Before administering the initial dose of sumatriptan succinate to a client with a migraine headache, it is most important to determine if the client’s history includes which problem?
Irritable bowel syndrome.
Coronary artery disease.
Seasonal allergic rhinitis.
Type 2 diabetes mellitus.
The Correct Answer is B
Choice A reason:
Irritable bowel syndrome (IBS) is not a primary concern when administering sumatriptan succinate. While IBS can cause significant discomfort and affect the quality of life, it does not pose a direct contraindication to the use of sumatriptan. Sumatriptan is primarily metabolized in the liver and excreted by the kidneys, and its use is not significantly impacted by gastrointestinal conditions like IBS1.
Choice B reason:
Coronary artery disease (CAD) is a critical consideration before administering sumatriptan succinate. Sumatriptan is a selective serotonin receptor agonist that causes vasoconstriction of cranial blood vessels to relieve migraine symptoms. However, it can also cause vasoconstriction in coronary arteries, which can be dangerous for clients with CAD. This can lead to serious cardiovascular events such as myocardial infarction or angina. Therefore, it is essential to assess for any history of CAD or other significant cardiovascular conditions before administering this medication.
Choice C reason:
Seasonal allergic rhinitis is not a significant concern when administering sumatriptan succinate. While allergic rhinitis can cause symptoms such as nasal congestion, sneezing, and itching, it does not interact with the pharmacological action of sumatriptan. Therefore, it is not a contraindication for the use of this medication.
Choice D reason:
Type 2 diabetes mellitus is not a primary concern when administering sumatriptan succinate. Although diabetes can increase the risk of cardiovascular disease, the presence of diabetes alone does not contraindicate the use of sumatriptan. However, it is important to consider the overall cardiovascular risk profile of the client, including any complications related to diabetes.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is A
Explanation
Choice A reason: Denying having coughing spells indicates that the antitussive medication benzonatate is effective. Benzonatate works by numbing the throat and lungs, reducing the cough reflex. This means that if the client is no longer experiencing coughing spells, the medication is performing its intended function.
Choice B reason: Being able to sleep through the night can be an indirect indicator of the medication’s effectiveness, but it is not as specific as denying coughing spells. While improved sleep might result from reduced coughing, it could also be influenced by other factors such as overall improvement in the client’s condition or the use of other medications.
Choice C reason: Expectorating bronchial secretions is not a direct indicator of the effectiveness of benzonatate. Benzonatate is an antitussive, meaning it suppresses the cough reflex rather than promoting the expulsion of mucus. Therefore, expectorating bronchial secretions would not be a primary measure of this medication’s effectiveness.
Choice D reason: Reporting reduced nasal discharge is also not a direct indicator of the effectiveness of benzonatate. This medication specifically targets the cough reflex and does not have a significant impact on nasal discharge. Reduced nasal discharge could be due to other factors or treatments.
Correct Answer is A
Explanation
Choice A reason: Bupropion is known to cause side effects such as insomnia and weight loss. These side effects are due to its stimulant properties, which can interfere with sleep patterns and suppress appetite1. Patients should be informed about these potential side effects so they can monitor their symptoms and seek medical advice if necessary.
Choice B reason: While changes in taste can occur with some medications, it is not a common side effect of bupropion. Therefore, it is not necessary to specifically instruct patients to notify their healthcare provider about changes in taste when taking bupropion.
Choice C reason: There is no specific requirement to administer bupropion with 8 ounces of water. Bupropion can be taken with or without food, and the amount of water consumed with the medication does not impact its effectiveness.
Choice D reason: Consuming tyramine-free foods is crucial for patients taking monoamine oxidase inhibitors (MAOIs) due to the risk of hypertensive crisis. However, bupropion is not an MAOI, so this dietary restriction is not applicable.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.